Artelo Biosciences, Inc.
ARTL
$1.04
$0.010.97%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.34M | 4.86M | 5.60M | 7.61M | 10.43M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 219.00K | 129.00K | 566.00K | 579.00K | 554.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 2.56M | 4.99M | 6.17M | 8.19M | 10.98M |
|
|
|||||
| Total Current Assets | 2.56M | 4.99M | 6.17M | 8.19M | 10.98M |
| Net Property, Plant & Equipment | 99.00K | 108.00K | 116.00K | 124.00K | 21.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 2.04M | 2.04M | 2.04M | 2.04M | 2.04M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.00K | 3.00K | 3.00K | 3.00K | 3.00K |
| Total Assets | 4.70M | 7.14M | 8.33M | 10.35M | 13.04M |
|
|
|||||
| Total Accounts Payable | 1.68M | 627.00K | 863.00K | 607.00K | 1.24M |
| Total Accrued Expenses | 61.00K | 36.00K | 44.00K | 83.00K | 30.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 35.00K | 34.00K | 33.00K | 31.00K | 23.00K |
| Total Finance Division Other Current Liabilities | -3.00K | -- | -- | -- | -- |
| Total Other Current Liabilities | -3.00K | -- | -- | -- | -- |
| Total Current Liabilities | 1.77M | 697.00K | 940.00K | 721.00K | 1.29M |
|
|
|||||
| Total Current Liabilities | 1.77M | 697.00K | 940.00K | 721.00K | 1.29M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 69.00K | 78.00K | 87.00K | 96.00K | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.84M | 775.00K | 1.03M | 817.00K | 1.29M |
|
|
|||||
| Common Stock & APIC | 53.20M | 52.94M | 52.73M | 52.53M | 52.27M |
| Retained Earnings | -50.14M | -46.36M | -45.23M | -42.79M | -40.31M |
| Treasury Stock & Other | -202.00K | -218.00K | -203.00K | -203.00K | -203.00K |
| Total Common Equity | 2.86M | 6.36M | 7.30M | 9.54M | 11.75M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 2.86M | 6.36M | 7.30M | 9.54M | 11.75M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 2.86M | 6.36M | 7.30M | 9.54M | 11.75M |
|
|
|||||